Prosecution Insights
Last updated: April 19, 2026

Constellation Pharmaceuticals Inc.

4 pending office actions

Portfolio Summary

4
Total Pending OAs
2
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18289467 MODULATORS OF TREX1 RAO, PADMAJA S 1627 Non-Final OA Nov 03, 2023
18288455 MODULATORS OF TREX1 RAO, PADMAJA S 1627 Non-Final OA Oct 26, 2023
18019634 2-((4S)-6-(4-CHLOROPHENYL)-1-METHYL-4H-BENZO[C]ISOXAZOLO[4,5-E]AZEPIN-4-YL)ACETAMIDE FOR TREATING THROMBOCYTHEMIA WEBB, WALTER E 1612 Final Rejection Feb 03, 2023
17628948 EZH2 INHIBITION IN COMBINATION THERAPIES FOR THE TREATMENT OF CANCERS DRAPER, LESLIE A ROYDS 1629 Final Rejection Jan 21, 2022

Managing Constellation Pharmaceuticals Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month